门冬氨酸鸟氨酸对肝纤维化大鼠的实验研究

耿嘉蔚; 彭伟; 范红; 陶健

门冬氨酸鸟氨酸对肝纤维化大鼠的实验研究

云南省第一人民医院消化科

详细信息

中图分类号: R575.2
计量
- 文章访问数: 2098
- HTML全文浏览量: 14
- PDF下载量: 1080
- 被引次数: 0
出版历程
- 出版日期: 2009-05-20

摘要

摘要: 目的通过大鼠肝纤维化动物模型,研究门冬氨酸鸟氨酸防止肝纤维化的作用。方法采用0.03%的硫代乙酰胺溶液腹腔注射制备大鼠肝纤维化模型,观察门冬氨酸鸟氨酸对大鼠肝功能指标、组织病理学改变和脯氨酸羟化酶表达的影响。结果门冬氨酸鸟氨酸能降低大鼠AST,ALT水平(P<0.05),减轻肝纤维化的病理改变进程。结论门冬氨酸鸟氨酸具有一定的抗肝纤维化作用。
- 肝纤维化 /
- 硫代乙酰胺 /
- 门冬氨酸鸟氨酸
Abstract: Objective To study the role of ornithine aspartate on preventing of liver fibrosis through the rat liver fibrotic model.Methods The rat liver fibrotic models were made with 0.03% TAA solution intraperitoneal injected.The effect of ornithine aspartate on rat liver function, histopathological changes and expression of proline hydroxylase were observed.Results Ornithine aspartate could reduce the levels of AST, ALT (P<0.05) , and alleviate the pathological changes of hepatic fibrosis process.Conclusion Ornithine aspartate has a certain role in anti-hepatic fibrosis.
- liver fibrosis /
- thioacetamide /
- Ornithine aspartate

HTML全文

参考文献(8)

[1]叶任高, 陆再英.内科学[M].第6版.北京:人民卫生出版社, 2006:430-436, 440-449.

[2]姚希贤, 徐克成.肝纤维化的基础与临床[M].上海:上海科技教育出版社, 2003:1-102.

[3]KircheisG, Wettsein M, Dahl S, et al.Clinnical efficacy of L-orni-thine-L-partate in the management of hepatic encephalopathy[J].Metab Brain Dis, 2002, 17 (4) :453-462.

[4] 陈孝志.瑞甘[J].中南医学, 2004, 2:254-255.

[5]Grerald K, Rudiger N, Constantin H, et al.The rapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and he-patic encephalopathy results of a placebo-controlled, double-blind study[J].Hepatology, 1997, 25:1351-1360.

[6]金晶, 曾凡波, 周燕, 等.门鸟氨酸对肝脏的保护作用[J].医药导报, 2003, 22:756-757.

[7]陈宏辉, 张明亮, 阳学风, 等.骨调素在酒精性肝纤维化中的表达[J].胃肠病学和肝病学杂志.2005, 14 (1) :45-49.

[8]吴荣雪, 高连相, 饶娴宜, 等.“抗肝纤1号”抗肝纤维化的实验研究[J].中西医结合杂志.1999, 9 (2) :33-37.

施引文献

资源附件(0)

访问统计